SCHEMBL28878337

SCHEMBL28878337

CN(C)Cc1ccn(Cc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
TSHR P16473 1/20 0.55
TAAR1 Q96RJ0 2/20 0.44
CYP2C19 P33261 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
TBXAS1 P24557 1/20 0.41
QPCT Q16769 1/20 0.41
CYP4Z1 Q86W10 1/20 0.41
QPCTL Q9NXS2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19160331 0.79 TP53 (0.50) CYP2C19CA12CA1CA2CA9
SCHEMBL28129581 0.77 CA12 (0.47) ALDH1A1TSHRCYP2C19CA12CA1
SCHEMBL28125757 0.76 CYP19A1 (0.46) ALDH1A1CYP2C19CA12CA1CA2
SCHEMBL1733332 0.76 CYP2C19 (0.50) ALDH1A1TSHRCYP2C19CA12CA1
SCHEMBL1680504 0.76 LOXL2 (0.50) ALDH1A1TAAR1CYP2C19CA12CA1
Chloromethane SCHEMBL28157121 0.74 TSHR (0.90) ALDH1A1TSHRTAAR1CA12CA1
SCHEMBL27369924 0.74 CYP1A2 (0.43) ALDH1A1TSHRCYP2C19CA12CA1
SCHEMBL24735547 0.73 TSHR (1.00) ALDH1A1TSHRTAAR1CA12CA1
SCHEMBL5014268 0.73 TSHR (1.00) ALDH1A1TSHRTAAR1CA12CA1
SCHEMBL27766437 0.73 TSHR (1.00) ALDH1A1TSHRTAAR1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110475777-A For treating and preventing new pyrido [2,3-b] benzazolyl compounds of bacterium infection HOFFMANN LA ROCHE 2019-11-19 CN disclosed